Genomic Valley Biotech Ltd vs Value 360 Communications Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 48.1 as of 30 Oct 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 0 on March 2022 to 0 on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Value 360 Communications Ltd changed from 0 on March 2022 to 0 on March 2026 . This represents a CAGR of 0.0% over 5 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Value 360 Communications Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 5 years The revenue of Genomic Valley Biotech Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0.04 crore. This represent the decline of -100% The revenue of Value 360 Communications Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Genomic Valley Biotech Ltd for the Sep '26 is ₹ -0.02 crore as compare to the Jun '26 ebitda of ₹ 0.02 crore. This represent the decline of -200% The ebitda of Value 360 Communications Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ -0.02 crore over 10 quarters. This represents a CAGR of NaN% The net profit of Value 360 Communications Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Value 360 Communications Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses, NFT & DFT etc, manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About Value 360 Communications Ltd

Value 360 Communications Limited was founded by Kunal Kishore and Gaurav Patra as an unregistered partnership firm in 2007.
Subsequently, a new Company was incorporated on April 17, 2009, under the name of Value 360 Communications Private Limited', dated April 17, 2009, which took over the business of the partnership firm.
Its status was converted into a Public Limited and the name of the Company was changed to Value 360 Communications Limited' via fresh Certificate of Incorporation dated January 29, 2025 issued by Central Processing Centre. V360 Communications' PR Communications vertical offers a comprehensive suite of strategic communication services, including Investor Relations, Crisis Communication, Reputation Management, Digital PR Solutions, and End-to-End Campaign Management. By 2011, Company expanded its regional footprint with the launch of Value 360 Communications offices in Mumbai and Bangalore, setting the stage for a broader market presence.

FAQs for the comparison of Genomic Valley Biotech Ltd and Value 360 Communications Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or Value 360 Communications Ltd?

Market cap of Genomic Valley Biotech Ltd is 14 Cr while Market cap of Value 360 Communications Ltd is 135 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and Value 360 Communications Ltd?

The stock performance of Genomic Valley Biotech Ltd and Value 360 Communications Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and Value 360 Communications Ltd?

As of October 31, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹48.1. On the other hand, Value 360 Communications Ltd stock price is INR ₹84.2.

How do dividend payouts of Genomic Valley Biotech Ltd and Value 360 Communications Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and Value 360 Communications Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.